GGrantIndex
← Leaderboards

Chia-Yang Liu

University Of Cincinnati

$8,052,846
Attributed
$8,052,846
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $806.3K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,052,846 · 6

By mechanism

R01$7,393,493 · 4
R21$659,353 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionGenesMorphogenesisTransgenic MiceMediatingCellsCorneaMolecularPathway InteractionsPlayHomeostasisMouse StrainsMaintenanceSignal PathwayLuciferasesOcular SurfaceLeadAdultPathogenesisAffectRegulationGene ExpressionGeneticVision

Grant awards (25)

Smad4 is a master regulator for extracellular matrix homeostasis in the corneal stroma$243,000
R21 · FY2025 · EY · contact PI
Molecular mechanism of corneal epithelial stratification and innervation$451,465
R01 · FY2022 · EY · contact PI
Molecular mechanism of corneal epithelial stratification and innervation$63,562
R01 · FY2022 · EY · contact PI
Molecular mechanism of corneal epithelial stratification and innervation$515,027
R01 · FY2021 · EY · contact PI
Role of Tgf-beta-signaling in corneal development and diseases$95,266
R21 · FY2021 · EY · contact PI
Role of Tgf-beta-signaling in corneal development and diseases$90,063
R21 · FY2021 · EY · contact PI
Molecular mechanism of corneal epithelial stratification and innervation$530,957
R01 · FY2020 · EY · contact PI
Role of Tgf-beta-signaling in corneal development and diseases$231,024
R21 · FY2020 · EY · contact PI
Molecular mechanism of corneal epithelial stratification and innervation$530,957
R01 · FY2019 · EY · contact PI
New Insights into the Ocular Surface in Health and Disease$420,103
R01 · FY2017 · EY · contact PI
New Insights into the Ocular Surface in Health and Disease$425,756
R01 · FY2016 · EY · contact PI
New Insights into the Ocular Surface in Health and Disease$424,075
R01 · FY2015 · EY · contact PI
Mouse Model for Eyelid Disease: Congenital Blepharophimosis$382,200
R01 · FY2015 · EY · contact PI
In vivo model for ocular surface disorder: Congenital Blepharophimosis$384,650
R01 · FY2014 · EY · contact PI
Mouse model for eyelid disease: Congenital blepharophimosis$372,875
R01 · FY2013 · EY · contact PI
Mouse model for eyelid disease: Congenital blepharophimosis$392,500
R01 · FY2012 · EY · contact PI
Mouse model for eyelid disease: Congenital blepharophimosis$392,500
R01 · FY2011 · EY · contact PI
ROLE OF KERATOCAN IN CORNEAL BIOLOGY$392,500
R01 · FY2010 · EY · contact PI
ROLE OF KERATOCAN IN CORNEAL BIOLOGY$392,500
R01 · FY2009 · EY · contact PI
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY$268,625
R01 · FY2005 · EY
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY$265,125
R01 · FY2004 · EY
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY$265,125
R01 · FY2003 · EY
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY$167,982
R01 · FY2002 · EY
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY$97,304
R01 · FY2002 · EY
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY$257,705
R01 · FY2001 · EY